clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00061087 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P17 | country | United States of America | Q30 |
P582 | end time | 2004-10-01 | |
P4135 | maximum age | 60 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 115 | |
P4844 | research intervention | methylphenidate | Q422112 |
bupropion | Q834280 | ||
methadone hydrochloride | Q26840915 | ||
P6153 | research site | Research Foundation For Mental Hygiene | Q30253457 |
P859 | sponsor | New York State Psychiatric Institute | Q9008737 |
P580 | start time | 1998-02-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Treatment of Adult ADHD in Methadone Patients |
Search more.